Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Beyond the Pill: Unlocking the Power of Liquid Suspensions | Contract Pharma

What are you searching for?

Sign in
Sponsored Content

Beyond the Pill: Unlocking the Power of Liquid Suspensions

Released By Mikart

As drug developers seek out novel solutions for geriatric and pediatric populations and patients with difficulty swallowing (dysphagia), liquid suspensions have become increasingly popular. However, while liquid suspensions have distinct advantages to pills, tablets, and traditional liquid solutions for specific patient populations, their unique formulation requirements make them highly challenging to develop and manufacture.

In order to meet rising demand, CDMO partners must have the necessary expertise to accelerate liquid suspension formulation development. In this exclusive thought leadership piece, Mikart’s very own Gus LaBella, Director of Formulation Development, shares the keys to liquid suspension formulation, including:

  • Understanding the unique characteristics of liquid suspensions 
  • Leveraging novel ion exchange technology 
  • Having experience with difficult-to-formulate liquid solutions 
  • Maintaining dedicated development, manufacturing, and production facilities

Request more information from Mikart

Request more information from Mikart

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics